Consensus statement on the diagnosis and treatment of autoimmune nodopathies from the Peripheral Neuropathy Association of the Chinese Society of Neurology

1Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Autoimmune nodopathis are a group of immune-mediated peripheral neuropathy, with antibodies to Ranvier nodal regions that includes anti-NF155, contactin1 (CNTN1), and contactin-associatedprotein1 (Caspr1) antibodies. Clinical features, neurophysiology, cerebrospinal fluid test, peripheral nerve imaging, sural neuropathology and antibody detection, diagnostic criteria were summarized in this consensus, as well as suggested principles of treatment with rituximab, glucocorticoids, plasma exchange and other immunotherapy medicines.

Cite

CITATION STYLE

APA

Liu, M., Pu, C., & Cui, L. (2025). Consensus statement on the diagnosis and treatment of autoimmune nodopathies from the Peripheral Neuropathy Association of the Chinese Society of Neurology. Neurology Asia, 30(2), 471–477. https://doi.org/10.54029/2025fsk

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free